| For: | Zhu BH, Zhan WH, Li ZR, Wang Z, He YL, Peng JS, Cai SR, Ma JP, Zhang CH. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J Gastroenterol 2007; 13(8): 1162-1169 [PMID: 17451194 DOI: 10.3748/wjg.v13.i8.1162] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/1162.htm |
| Number | Citing Articles |
| 1 |
Vinit Sharma, Khushbu Sharma, Ankita Semwal, Ankita Arora, Sakshi Bansal, Anjali Aggarwal. Chemical and Immunological Strategies in Cancer Therapeutics. 2026; doi: 10.1007/978-981-95-9777-2_2
|
| 2 |
|
| 3 |
Jiaying Cai, Xiyue Tan, Qichao Hu, Huafeng Pan, Maoyuan Zhao, Cui Guo, Jinhao Zeng, Xiao Ma, Yanling Zhao. Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance. Drug Design, Development and Therapy 2024; doi: 10.2147/DDDT.S466470
|
| 4 |
Zhe Cheng, Zhifa Zhang, Yu Han, Jing Wang, Yongyong Wang, Xiaoqiang Chen, Yundong Shao, Yong Cheng, Weilong Zhou, Xiaolei Lu, Zhengqi Wu. A review on anti-cancer effect of green tea catechins. Journal of Functional Foods 2020; 74 doi: 10.1016/j.jff.2020.104172
|
| 5 |
Pallavi Chand, Hitesh Kumar, Rupshee Jain, Atul Jain, Vikas Jain. Flavonoids as omnipotent candidates for cancer management. South African Journal of Botany 2023; 158 doi: 10.1016/j.sajb.2023.05.025
|
| 6 |
Qiang Wei, Yi-han Zhang. Flavonoids with Anti-Angiogenesis Function in Cancer. Molecules 2024; 29(7) doi: 10.3390/molecules29071570
|
| 7 |
Triparna Sen, Shuvojit Moulik, Anindita Dutta, Paromita Roy Choudhury, Aniruddha Banerji, Shamik Das, Madhumita Roy, Amitava Chatterjee. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sciences 2009; 84(7-8) doi: 10.1016/j.lfs.2008.11.018
|
| 8 |
Oana Tudoran, Olga Soritau, Ovidiu Balacescu, Loredana Balacescu, Cornelia Braicu, Meda Rus, Claudia Gherman, Piroska Virag, Florin Irimie, Ioana Berindan‐Neagoe. Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells. Journal of Cellular and Molecular Medicine 2012; 16(3) doi: 10.1111/j.1582-4934.2011.01346.x
|
| 9 |
Akira Shibata, Kiyotaka Nakagawa, Phumon Sookwong, Tsuyoshi Tsuduki, Shuhei Tomita, Hitoshi Shirakawa, Michio Komai, Teruo Miyazawa. Tocotrienol Inhibits Secretion of Angiogenic Factors from Human Colorectal Adenocarcinoma Cells by Suppressing Hypoxia-Inducible Factor-1α. The Journal of Nutrition 2008; 138(11) doi: 10.3945/jn.108.093237
|
| 10 |
Changwei Liu, Penghui Li, Zhihao Qu, Wei Xiong, Ailing Liu, Sheng Zhang. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors. Molecules 2019; 24(9) doi: 10.3390/molecules24091726
|
| 11 |
Mateusz Kciuk, Manzar Alam, Nemat Ali, Summya Rashid, Pola Głowacka, Rajamanikandan Sundaraj, Ismail Celik, Esam Bashir Yahya, Amit Dubey, Enfale Zerroug, Renata Kontek. Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. Molecules 2023; 28(13) doi: 10.3390/molecules28135246
|
| 12 |
Jae-Wook Oh, Manikandan Muthu, Suraj Shiv Charan Pushparaj, Judy Gopal. Anticancer Therapeutic Effects of Green Tea Catechins (GTCs) When Integrated with Antioxidant Natural Components. Molecules 2023; 28(5) doi: 10.3390/molecules28052151
|
| 13 |
Esther Melgarejo, Miguel Ángel Medina, Francisca Sánchez-Jiménez, José Luis Urdiales. Targeting of histamine producing cells by EGCG: a green dart against inflammation?. Journal of Physiology and Biochemistry 2010; 66(3) doi: 10.1007/s13105-010-0033-7
|
| 14 |
Mohd Shuaib, Prem Prakash Kushwaha, Kumari Sunita Prajapati, Atul Kumar Singh, Rahul Sharma, Shashank Kumar. Obesity and Cancer. 2021; doi: 10.1007/978-981-16-1846-8_9
|
| 15 |
Namin Duan, Xiaohui Hu, Rui Zhou, Yuru Li, Wenhui Wu, Ning Liu. A Review on Dietary Flavonoids as Modulators of the Tumor Microenvironment. Molecular Nutrition & Food Research 2023; 67(7) doi: 10.1002/mnfr.202200435
|
| 16 |
Bhavana Jodha, Sunita Patel. Nanotechnology Based Delivery of Phytoconstituents and Cosmeceuticals. 2024; doi: 10.1007/978-981-99-5314-1_3
|
| 17 |
Vaishali Aggarwal, Hardeep Singh Tuli, Mousumi Tania, Saumya Srivastava, Erin E. Ritzer, Anjana Pandey, Diwakar Aggarwal, Tushar Singh Barwal, Aklank Jain, Ginpreet Kaur, Katrin Sak, Mehmet Varol, Anupam Bishayee. Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement. Seminars in Cancer Biology 2022; 80 doi: 10.1016/j.semcancer.2020.05.011
|
| 18 |
Chung S. Yang, Xin Wang, Gang Lu, Sonia C. Picinich. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nature Reviews Cancer 2009; 9(6) doi: 10.1038/nrc2641
|
| 19 |
Maclaine Parish, Gaelle Massoud, Dana Hazimeh, James Segars, Md Soriful Islam. Green Tea in Reproductive Cancers: Could Treatment Be as Simple?. Cancers 2023; 15(3) doi: 10.3390/cancers15030862
|
| 20 |
Alessandro Lentini, Claudio Tabolacci, Bruno Provenzano, Stefania Rossi, Simone Beninati. Phytochemicals and protein–polyamine conjugates by transglutaminase as chemopreventive and chemotherapeutic tools in cancer. Plant Physiology and Biochemistry 2010; 48(7) doi: 10.1016/j.plaphy.2010.02.010
|
| 21 |
Chung S. Yang, Hong Wang, Guang Xun Li, Zhihong Yang, Fei Guan, Huanyu Jin. Cancer prevention by tea: Evidence from laboratory studies. Pharmacological Research 2011; 64(2) doi: 10.1016/j.phrs.2011.03.001
|
| 22 |
Xiao-Hui Hu, Li-Ya Ding, Wei-Xue Huang, Xian-Mei Yang, Fang Xie, Min Xu, Long Yu. (−)-Epigallocatechin-3-gallate, a potential inhibitor to human dicarbonyl/l-xylulose reductase. The Journal of Biochemistry 2013; 154(2) doi: 10.1093/jb/mvt039
|
| 23 |
Chao-You Huang, Zheng Han, Xi Li, Hui-Hua Xie, Shan-Shan Zhu. Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer. Oncology Letters 2017; 14(3) doi: 10.3892/ol.2017.6641
|
| 24 |
Hang Wang, Ying-Jiun Lai, Yi-Lin Chan, Tsung-Lin Li, Chang-Jer Wu. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Cancer Letters 2011; 305(1) doi: 10.1016/j.canlet.2011.02.023
|
| 25 |
Baraa K Al-Khazraji, Philip J Medeiros, Nicole M Novielli, Dwayne N Jackson. An automated cell-counting algorithm for fluorescently-stained cells in migration assays. Biological Procedures Online 2011; 13(1) doi: 10.1186/1480-9222-13-9
|
| 26 |
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, Leila Kooshki, Kassidy Webber, Anupam Bishayee. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review. Cancer and Metastasis Reviews 2024; 43(1) doi: 10.1007/s10555-023-10136-9
|
| 27 |
Issei DAIRAKU, Yunkyung HAN, Noriyuki YANAKA, Norihisa KATO. Inhibitory Effect of Curcumin on IMP Dehydrogenase, the Target for Anticancer and Antiviral Chemotherapy Agents. Bioscience, Biotechnology, and Biochemistry 2010; 74(1) doi: 10.1271/bbb.90568
|
| 28 |
Nayana Prakash, Pavan Gollapalli, Tamizh Selvan Gnanasekaran. Systems-level insights into EGCG-mediated modulation of MAPK signaling in Helicobacter pylori-linked gut and gastric diseases. In Silico Research in Biomedicine 2026; 2 doi: 10.1016/j.insi.2026.100422
|
| 29 |
Ren-You Gan, Hua-Bin Li, Zhong-Quan Sui, Harold Corke. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Critical Reviews in Food Science and Nutrition 2018; 58(6) doi: 10.1080/10408398.2016.1231168
|
| 30 |
Chung S. Yang, Xin Wang. Green Tea and Cancer Prevention. Nutrition and Cancer 2010; 62(7) doi: 10.1080/01635581.2010.509536
|
| 31 |
|
| 32 |
Hongju Wu, Yan Xin, Yuping Xiao, Jing Zhao. Low-Dose Docetaxel Combined with (−)-Epigallocatechin-3-Gallate Inhibits Angiogenesis and Tumor Growth in Nude Mice with Gastric Cancer Xenografts. Cancer Biotherapy and Radiopharmaceuticals 2012; 27(3) doi: 10.1089/cbr.2011.1103
|
| 33 |
Islam Rady, Hadir Mohamed, Mohamad Rady, Imtiaz A. Siddiqui, Hasan Mukhtar. Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea. Egyptian Journal of Basic and Applied Sciences 2018; 5(1) doi: 10.1016/j.ejbas.2017.12.001
|
| 34 |
Yike Jiang, Ziyi Jiang, Lan Ma, Qingrong Huang. Advances in Nanodelivery of Green Tea Catechins to Enhance the Anticancer Activity. Molecules 2021; 26(11) doi: 10.3390/molecules26113301
|
| 35 |
Ehsan Ghaedi, Nima Rezaei, Maryam Mahmoudi. Nutrition and Immunity. 2019; doi: 10.1007/978-3-030-16073-9_12
|
| 36 |
HONGJU WU, YAN XIN, CHONGAN XU, YUPING XIAO. Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts. Experimental and Therapeutic Medicine 2012; 3(4) doi: 10.3892/etm.2012.448
|
| 37 |
ANTIOXIDANT PROPERTIES OF MATCHA IN DRY EYE DISEASE PREVENTION: CAN MATCHA POLYPHENOLS IMPROVE OCULAR HYDRATION?. International Journal of Innovative Technologies in Social Science 2025; 2(3(47)) doi: 10.31435/ijitss.3(47).2025.3515
|
| 38 |
|
| 39 |
Shao-Jung Hsu, Sun-Sang Wang, I-Fang Hsin, Fa-Yauh Lee, Hui-Chun Huang, Teh-Ia Huo, Wen-Shin Lee, Han-Chieh Lin, Shou-Dong Lee. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis. Clinical Science 2014; 126(9) doi: 10.1042/CS20130215
|
| 40 |
Magdalena Tyczyńska, Paweł Kędzierawski, Kaja Karakuła, Jacek Januszewski, Krzysztof Kozak, Monika Sitarz, Alicja Forma. Treatment Strategies of Gastric Cancer—Molecular Targets for Anti-angiogenic Therapy: a State-of-the-art Review. Journal of Gastrointestinal Cancer 2021; 52(2) doi: 10.1007/s12029-021-00629-7
|
| 41 |
Mehrdad Hashemi, Farnaz Azizi, Niloofar AbolfathyNajmabady, Samira Moradi, Munes Ghorbanalinia, Sima Orouei, Behdokht Jamali, Rasoul Raesi, Faramarz Khosravi, Maliheh Entezari, Mina Alimohammadi, Kiavash Hushmandi, Mitra Behroozaghdam. Prostate Cancer: Molecular Events and Therapeutic Modalities. 2024; doi: 10.1007/978-981-97-4612-5_2
|
| 42 |
Xudong Tang, Qunzhou Zhang, Anh D. Le, Keyuan Zhou. Tea in Health and Disease Prevention. 2013; doi: 10.1016/B978-0-12-384937-3.00066-5
|
| 43 |
Chung S. Yang, Hong Wang. Mechanistic issues concerning cancer prevention by tea catechins. Molecular Nutrition & Food Research 2011; 55(6) doi: 10.1002/mnfr.201100036
|
| 44 |
Saleh A. Almatroodi, Ahmad Almatroudi, Amjad Ali Khan, Fahad A. Alhumaydhi, Mohammed A. Alsahli, Arshad Husain Rahmani. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Molecules 2020; 25(14) doi: 10.3390/molecules25143146
|
| 45 |
Shui-Ming Wang, Yu Sun, Xiu Zhang, Min Li, De-Song Kong, Shu-Liang Huang, Hao Chen, Xiao-Feng Wang, Ming-Zhi Fang, Hei-Ying Jin, Yu Wang. Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats. World Journal of Gastroenterology 2020; 26(17): 2064-2081 doi: 10.3748/wjg.v26.i17.2064
|
| 46 |
Aleena Sinha, Praveen K. Kujur, Rana P. Singh. Molecular Targets in Cancer Therapy. 2025; doi: 10.1007/978-981-96-7336-0_6
|
| 47 |
Pratik Shriwas, Xiaozhuo Chen, A. Douglas Kinghorn, Yulin Ren. Plant‐derived glucose transport inhibitors with potential antitumor activity. Phytotherapy Research 2020; 34(5) doi: 10.1002/ptr.6587
|
| 48 |
Yanling Ai, Ziyi Zhao, Hengyi Wang, Xiaomei Zhang, Weihan Qin, Yanlei Guo, Maoyuan Zhao, Jianyuan Tang, Xiao Ma, Jinhao Zeng. Pull the plug: Anti‐angiogenesis potential of natural products in gastrointestinal cancer therapy. Phytotherapy Research 2022; 36(9) doi: 10.1002/ptr.7492
|
| 49 |
Chung Yang, Hong Wang. Cancer Preventive Activities of Tea Catechins. Molecules 2016; 21(12) doi: 10.3390/molecules21121679
|
| 50 |
Mehdi Sharifi-Rad, Raffaele Pezzani, Marco Redaelli, Maira Zorzan, Muhammad Imran, Anees Ahmed Khalil, Bahare Salehi, Farukh Sharopov, William C. Cho, Javad Sharifi-Rad. Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer. Molecules 2020; 25(3) doi: 10.3390/molecules25030467
|
| 51 |
Natural Products and Cancer Signaling: Isoprenoids, Polyphenols and Flavonoids. The Enzymes 2014; 36 doi: 10.1016/B978-0-12-802215-3.00010-0
|
| 52 |
Jong-Hyung Park, Jin-Hee Seo, Hee-Yeon Jeon, Sun-Min Seo, Han-Kyul Lee, Jin-Il Park, Jun-Young Kim, Yang-Kyu Choi. <p>Lentivirus-Mediated VEGF Knockdown Suppresses Gastric Cancer Cell Proliferation and Tumor Growth in vitro and in vivo</p>. OncoTargets and Therapy 2020; doi: 10.2147/OTT.S234344
|
| 53 |
A.M. El-Mowafy, M.M. Al-Gayyar, H.A. Salem, M.E. El-Mesery, M.M. Darweish. Novel chemotherapeutic and renal protective effects for the green tea (EGCG): Role of oxidative stress and inflammatory-cytokine signaling. Phytomedicine 2010; 17(14) doi: 10.1016/j.phymed.2010.08.004
|
| 54 |
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth. Natural products targeting tumour angiogenesis. British Journal of Pharmacology 2025; 182(10) doi: 10.1111/bph.16232
|
| 55 |
Dipti Gatne, Veeranjaneyulu Addepalli. Biochemical Basis and Therapeutic Implications of Angiogenesis. 2013; doi: 10.1007/978-1-4614-5857-9_26
|
| 56 |
Shuang SONG, Ye-Wei HUANG, Yang TIAN, Xuan-Jun WANG, Jun SHENG. Mechanism of action of (–)-epigallocatechin-3-gallate: auto-oxidation-dependent activation of extracellular signal-regulated kinase 1/2 in Jurkat cells. Chinese Journal of Natural Medicines 2014; 12(9) doi: 10.1016/S1875-5364(14)60100-X
|
| 57 |
Jerry McLarty, Rebecca L.H. Bigelow, Mylinh Smith, Don Elmajian, Murali Ankem, James A. Cardelli. Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitro
. Cancer Prevention Research 2009; 2(7) doi: 10.1158/1940-6207.CAPR-08-0167
|
| 58 |
Gyuman Park, Byung Sun Yoon, Jai-Hee Moon, Bona Kim, Eun Kyoung Jun, Sejong Oh, Hyunggee Kim, Hea Joon Song, Joo Young Noh, ChilHwan Oh, Seungkwon You. Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling Pathway. Journal of Investigative Dermatology 2008; 128(10) doi: 10.1038/jid.2008.103
|
| 59 |
Wen-Ying Huang, Jia-Ni Lin, Jer-Tsong Hsieh, Shen-Chieh Chou, Chih-Ho Lai, Eun-Jin Yun, U-Ging Lo, Rey-Chen Pong, Jui-Hsiang Lin, Yu-Hsin Lin. Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy. ACS Applied Materials & Interfaces 2016; 8(45) doi: 10.1021/acsami.6b10029
|
| 60 |
Anna Hsu, Tammy M Bray, Emily Ho. Anti-inflammatory activity of soy and tea in prostate cancer prevention. Experimental Biology and Medicine 2010; 235(6) doi: 10.1258/ebm.2010.009335
|
| 61 |
Wenjing Tang, Huanlei Song, Wei Cai, Xiuhua Shen. Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (−)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells. Nutrients 2015; 7(10) doi: 10.3390/nu7105437
|
| 62 |
Osamu Hashimoto, Anna Nakamura, Toru Nakamura, Hideki Iwamoto, Masuda Hiroshi, Kinya Inoue, Takuji Torimura, Takato Ueno, Michio Sata. Methylated-(3′′)-Epigallocatechin Gallate Analog Suppresses Tumor Growth in Huh7 Hepatoma Cells Via Inhibition of Angiogenesis. Nutrition and Cancer 2014; 66(4) doi: 10.1080/01635581.2013.783601
|
| 63 |
Kazuo Yamagata, Motoki Tagami, Yukio Yamori. Dietary polyphenols regulate endothelial function and prevent cardiovascular disease. Nutrition 2015; 31(1) doi: 10.1016/j.nut.2014.04.011
|
| 64 |
Anna Hsu, Richard S. Bruno, Christiane V. Löhr, Alan W. Taylor, Rodrick H. Dashwood, Tammy M. Bray, Emily Ho. Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model. The Journal of Nutritional Biochemistry 2011; 22(5) doi: 10.1016/j.jnutbio.2010.04.006
|
| 65 |
Ahmed S. Doghish, Mohamed Bakr Zaki, Abdulrahman Hatawsh, Nourhan Elfar, Nora A. A. Alhamshry, Mai A. Abd-Elmawla, Nora M. Aborehab, Abdullah F. Radwan, Rewan Moussa, Sherif S. Abdel Mageed, Mustafa Ahmed Abdel-Reheim, Osama A. Mohammed, Hanan Elimam. Alternative medicines in oncology: a focus on natural products against gastric cancer. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(10) doi: 10.1007/s00210-025-04058-2
|
| 66 |
Manzar Alam, Sabeeha Ali, Ghulam Md. Ashraf, Anwar L. Bilgrami, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan. Epigallocatechin 3-gallate: From green tea to cancer therapeutics. Food Chemistry 2022; 379 doi: 10.1016/j.foodchem.2022.132135
|
| 67 |
Guy G. Chabot, Yasmine S. Touil, Minh Hien Pham, Daniel Dauzonne. Alternative and Complementary Therapies for Cancer. 2010; doi: 10.1007/978-1-4419-0020-3_23
|
| 68 |
K. D. Crew, K. A. Ho, P. Brown, H. Greenlee, T. B. Bevers, B. Arun, N. Sneige, C. Hudis, H. L. McArthur, J. Chang, M. Rimawi, T. L. Cornelison, J. Cardelli, R. M. Santella, A. Wang, S. M. Lippman, D. L. Hershman. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor‐negative breast cancer. Journal of Human Nutrition and Dietetics 2015; 28(3) doi: 10.1111/jhn.12229
|
| 69 |
Young Woo Cheon, Kwan Chul Tark, Yang Woo Kim. Better Survival of Random Pattern Skin Flaps Through the Use of Epigallocatechin Gallate. Dermatologic Surgery 2012; 38(11) doi: 10.1111/j.1524-4725.2012.02566.x
|
| 70 |
Peng-Bo DENG, Cheng-Ping HU, Zeng XIONG, Hua-Ping YANG, Yuan-Yuan LI. Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2. Chinese Journal of Natural Medicines 2013; 11(3) doi: 10.1016/S1875-5364(13)60023-0
|
| 71 |
Jing Chen, Jieqiong Wang, Lei Lin, Lijun He, Yuanyuan Wu, Li Zhang, Zhengfang Yi, Yihua Chen, Xiufeng Pang, Mingyao Liu. Inhibition of STAT3 Signaling Pathway by Nitidine Chloride Suppressed the Angiogenesis and Growth of Human Gastric Cancer. Molecular Cancer Therapeutics 2012; 11(2) doi: 10.1158/1535-7163.MCT-11-0648
|
| 72 |
Sivanantham Banudevi, Sethuraman Swaminathan, Krishnan Uma Maheswari. Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy. Nutrition and Cancer 2015; 67(7) doi: 10.1080/01635581.2015.1073762
|
| 73 |
Efstratios Athanasiou, Georgios-Ioannis Verras, Savvas Papageorgiou, Ioannis Kelesis, Athanasios Gatsis, Christina Karaoulani, Ioannis Stouras, Panagiotis Kanatas, Elmina-Marina Saitani, Maria-Eleni Oikonomou, Danae-Anastasia Vlassi, Maria Vasileiou, Christos Tsagkaris, Athanasios Alexiou, Mohammad Amjad Kamal. The Association Between the Risk of Breast Cancer and Epigallocatechin-
3-Gallate Intake: A Literature Review of a Potential Chemopreventive
Agent. Current Medicinal Chemistry 2022; 29(40) doi: 10.2174/0929867329666220726153412
|
| 74 |
|
| 75 |
Manoj Kumar, Sunil Kumar Dhatwalia, D. K. Dhawan. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis. Tumor Biology 2016; 37(11) doi: 10.1007/s13277-016-5330-5
|
| 76 |
Robert Kleszcz, Aleksandra Majchrzak‐Celińska, Wanda Baer‐Dubowska. Tannins in cancer prevention and therapy. British Journal of Pharmacology 2025; 182(10) doi: 10.1111/bph.16224
|
| 77 |
Salma Hazgui, Arnaud Bonnomet, Béatrice Nawrocki-Raby, Magali Milliot, Christine Terryn, Jérôme Cutrona, Myriam Polette, Philippe Birembaut, Jean-Marie Zahm. Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respiratory Research 2008; 9(1) doi: 10.1186/1465-9921-9-33
|
| 78 |
H‐J. Jung, C‐J. Lim. The Antiangiogenic and Antinociceptive Activities of n‐Propyl Gallate. Phytotherapy Research 2011; 25(10) doi: 10.1002/ptr.3452
|
| 79 |
M. W. Laschke, C. Schwender, C. Scheuer, B. Vollmar, M. D. Menger. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Human Reproduction 2008; 23(10) doi: 10.1093/humrep/den245
|
| 80 |
Sameen Ruqia Imadi, Isra Mahmood, Alvina Gul. Plant and Human Health, Volume 1. 2018; doi: 10.1007/978-3-319-93997-1_5
|
| 81 |
|